Humoral immunity developed by DNA vaccine INO-4800 is effective against SARS-CoV-2 variants
A team of international scientists recently demonstrated that antibodies generated in response to the DNA vaccine INO-4800 can effectively neutralize …
Home ยป
The use of mammalian cell surface display for rapid characterization of SARS-CoV-2 variants
A research group from the U.S. demonstrated the practicality of a spike display system in order to accelerate vaccine design, …
Researchers offer large-scale screening of potential broad-spectrum SARS-CoV-2 antivirals
The search for effective and safe antivirals against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen responsible for the …
Absence of natural killer cell receptor associated with severe COVID-19
The course and severity of COVID-19 in individual patients is largely influenced by the interaction between the SARS-CoV-2 coronavirus and …
Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2
Researchers from Cuba, China, and France have demonstrated the potential of coupling a viral antigen with the tetanus toxoid protein …
Molecular surveillance of SARS-CoV-2 spike protein mutations using CovRadar
COVID-19 disease is caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 was declared a pandemic …
What are Deacetylase Inhibitors?
Histone deacetylases are enzymes involved in the modification of histones in order to allow DNA to wrap around them tightly. …
FDA Approves Kineret (anakinra) for the Treatment of Deficiency of IL-1 Receptor Antagonist (DIRA)
WALTHAM, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE) — Sobi™, an international biopharmaceutical company dedicated to rare diseases, announced that the …